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Abstract  
Introduction: Few data are available concerning the prevalence of autoimmune disease in chronic lymphocytic 
leukemia patients at diagnosis as well as at clinical outcome. This study was carried out in the radioisotope center in 
Khartoum - department of blood bank from the period 2 August to 20 September 2008. 
Aim: The aim of this study is to detect the presence of auto-immune antibody among chronic lymphocytic leukemia 
patients.  
Method: Two ml of venous blood were collected from 50 CLL patients of both sexes and different ages. All 
specimens were tested for autoimmune antibody by using direct Coomb's by the immune diffusion gel technique. A 
structured pre tested questionnaire was used to collect the qualitative data   
Results Analysis showed that 38% of the patients have autoimmune antibody in their serum. Also it confirmed that 
there is significant difference between the presence of autoimmune antibody, jobs (0.004), the duration of the disease 
(0.019) and there is no significant difference between the presence of autoimmune antibody and age (0.051) as well 
as the sex of the patients (0.960). 
Recommendations: CLL patient must be investigated for autoanibodies, which can help in improving management 
and enhance controlling the prognosis of the patient.   
 
 ةصلاخلا 
ةمدقم: تانايبلا تملاهرفو  ةليلقصوصخب راشتنا ةعينم دادضلاا تاذلا نمزملا يوافميللا مدلا ضاضيبا ضرمب ةقلعتملا دنع تناكأ ءاوس اصيخشتل وا 
يف لاتاجرخم لاةيريرس .دقو ةساردلا هذه تيرجأ يف زكرم ةعشملا رئاظنلا بموطرخلا يف مسق مدلا كنب يف ةرتفلا  نم 2 سطسغأايل 20 ربمتبس2008. 
فدهلا نم فدهلا :وه ةساردلا هذه  نع فشكلاةعينم دادضلاا تاذلا نيب ىضرم ضاضيبا  يوافميللا مدلا نمزملا. 
لا رطيق:ة   عمج مت2 ددعل يديرولا مدلا نم لم50  ضيرمنيسنجلا نم نم و .رامعلأا فلتخم  تانيعلا لك يف تاذلا ةعينم دادضلاا نع فشكلا مت
تخا مادختساب .ةيعونلا تانايبلا عمجل ) اقبسم ربتخم( نايبتسا مادختسا متو .لجلا يف يعانملا راشتنلاا ةينقتبو رشابملا سبموك راب 
جئاتنلا: جئاتن ترهظأ ليلحتلا  نأ38٪ نم ىضرم ضاضيبا  يوافميللا مدلا نمزملا تاذلا ةعينم دادضا مهيدل. دكأوجئاتنلا ت  اضيأ يونعم قرف دوجو 
هظ ةنراقم دنعرو  ةعينم دادضلااتاذلا و  ةفيظولا عون(0.004 ةدمو ،)ضرملا (0.019 )كانه سيلو  يونعم قرف نيب روهظ دادضلاا  لاورمع 
(0.051 كلذكو ،)سنج (ضرملا0.960.) 
تايصوتلا : نمزملا يوافميلا مدلا ضاضيبا يضرم لك يدل ةداضملا ماسجلاا نع فشكلا بجي ، هنا ثيح  نأ نكمييدعاس يف اعملاو ةجل لا ةرطيس
ىلع ضرملا روطت هلبقتسم نيسحتو. 
 




Chronic lymphocytic leukemia (CLL) is a monoclonal disorder characterized by a progressive 
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accumulation of functionally incompetent lymphocytes and affects mostly the B lymphocytes and causes 
suppression of the immune system, failure of the bone marrow and infiltration of malignant cells into 
organs. Although chronic lymphocytic leukemia starts in the bone marrow it can spread to the blood, lymph 
nodes, spleen, liver, central nervous system (CNS), and other organs as a result of a prolonged lifespan with 
impaired apoptosis, it does not usually form a solid mass or tumor.(1)  
Chronic lymphocytic leukemia (CLL) is most common in the Western world but rare in the Far East (e.g. 
China, Japan), where it is estimated to comprise 10% of all leukemias.(2) 
In contrast to other forms of leukaemias there is no incidence induced by previous chemotherapy or 
radiotherapy. There is a seven-fold increased risk of CLL in the close relatives of patients. It has a peak 
incidence between 60 and 80 years of age and more common in males. The etiology is unknown but there 
are geographical variations in incidence.(2) 
The link between autoimmunity and chronic lymphocytic leukemia may result from a common aetiological 
origin (genetic, hormonal, or environmental factors) or alternatively, from paraneoplastic syndromes. A 
large number of auto antibodies have been identified, but little is known about their clinical significance. 
The commonest laboratory findings are: anemia secondary to bone marrow involvement with CLL, splenic 
sequestration of red blood cells, autoimmune hemolytic anemia and pure RBCs aplasia and 
thrombocytopenia due to splenic sequestration and auto-immune thrombocytopenia.(3) 
The autoimmunity in B-CLL is observed much more commonly in patients treated with fludarabine, which 
is known to suppress the circulating CD4+ T cells. (4)  
A striking feature of autoimmunity in CLL is that it appears to be directed against constituents of the blood 
with no documented propensity to other targets. However, despite the importance of this immune 
deregulations in CLL, the causes of autoantibody production remain unclear.(3) 
Some recent researches were performed to determine whether these auto antibodies are the products of the 
neoplastic B-CLL clones. Immunoglobulins (Ig) were eluted from washed red blood cells (RBCs) obtained 
from two CLL patients at the time they had autoimmune (DAT-direct antiglobulin test-positive) hemolytic 
anemia. The light chain phenotypes of these eluted auto antibodies were determined and found to be 
monotypic with exact correlation to the light chain expressed on the surface of the B-CLL clones. The 
eluted antibodies from RBC of DAT negative patients or normal volunteers failed to demonstrate 
measurable amounts of Ig. In contrast, Ig eluted from RBCs obtained from SLE patients with DAT positive 
hemolytic anemia was found to be polyclonal auto antibodies exhibiting both light chain types. 
Furthermore, CD5+B lymphocytes obtained from the same above mentioned two CLL patients (DAT+) 
produced, in vitro under stimulation with phorbal myristate acetate (PMA), monoclonal antibodies which 
react and bind to RBC. Thus these studies provide direct evidence demonstrating that the antibodies causing 
the autoimmune hemolytic anemia in the two CLL patients are the products of the B-CLL obtained from 
neoplastic clones. (5) 
The main objective of this study is to detect the auto immune antibody among chronic lymphocytic 
leukemia Sudanese patients, also it aimed to determine if there is a relationship between the presence of 
autoimmune antibody and some factors like age, sex, job of the patients as well as the duration of this 
disease. 
Material and method 
This study was carried out in the radioisotope center of Khartoum, Sudan during the period from 2 August 
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to 20 September, 2008. A total of 50 venous blood samples were taken (using clean venopuncture 
technique) from differently aged CLL Sudanese patients from both sexes. A structured pre tested 
questionnaire was used to collect the qualitative data. A written informed consent was obtained from all 
research subjects after the explanation of the research objectives, and any refusal was respected and the 
confidentiality of the data was ensured.   
Antibodies detection was done by immuno diffusion gel technique “The DiaClon Rh-subgroups” micro-card 
was used according to the standerd guidelines. Known positive and negative controls were included in 
accordance with the relevant guidelines of quality assurance.(6) 
The results were interpreted as follows: 
Positive: agglutinated cells forming a discrete red line (++++) on the surface of the gel or agglutinates 
dispersed in gel (+++; ++; +) depending on the size and position of the agglutinates in the gel. Negative: 
Compact button of red cells in the bottom of the micro-tube (Figure 1). 
 
Results  
A total of 50 CLL patients participated in this study, 68% (n=34) of them were males and the remaining 
32% (n=16) were females. Majority of them were from Western Sudan (59.5%): Darfour 33.3% and 
Kordofan 26.2%) (Figure 2).  
The antibody screening test (direct Coombs test) result showed that 38% (n=19) of the study population 
had autoimmune antibodies (Table 1). 
According to the job distribution the result showed that all the females were housewives and 18 (52%) of 
the males had outdoor jobs (farmer) and the remaining have indoor jobs; such as office work and others 
(Table 2).   
Regarding the presence of autoatibodies,  the study also showed that there was a highly significant 
difference between the appearance of the autoantibodies and the type of the jobs (0.004) and the duration 







Figure 1:  Gel test 
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Figure 2: Frequency of residence among study population 
           






Table 2: Frequency and significance of autoantibody according to occupations. 
 Positive  negative Chi-square P.value 
Farmer 11 7  
8.476 
 
0.004 Not farmer 2 14 
 
 
Table (3) Frequency and significance of autoantibody according to duration of the disease (in 
months). 
Duration Positive  negative Chi-square P.value 
3 -9 3 15   
Antibody screening test Frequency  Percent  
Positive  19 (6 females\13males) 38% 
Negative  31(10 females\ 21males) 62% 
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10-16 9 13 7.902 0.019 






Gender distribution among the study population shows higher incidence of CLL in males than females with 
a ratio of 1.7: 1. This result is similar to that of Matutes E, Polliak A [The incidence of CLL is higher in 
males than in females, with a male-to-female ratio of 1.7:1. (1) 
Frequency of residence (or tribe) among study population found increased CLL in western Sudanese patient 
especially those from Darfour and Kourdofan.This may be due to their life style or some environmental 
factors which have to be studied. 
Thirty eight percent of the study population have autoimmune antibodies in their serum with positive direct 
Coomb's test and the others 62 % were negative, similar to that previously reported by Rear (7) who found 
that 30% of patients developed autoimmune hemolytic anemia (AIHA). In contrast Katrina Vanura (8) found 
that 22(11.8%) CLL patients of 186 patients suffered from autoimmune antibodies. Clinically, Barcellini (9) 
found 16% of CLL patients to suffer from autoimmune other than disease stage, no clinical or prognostic 
data were included in this study. Fifty-two cases of (AIHA) were observed within a series of 1203 patients 
(4.3%) with (CLL) followed at a single institution as reported by Francesca (10). These different results may 
be due to genetic factors or sample size or may be due to the different methods used to test for the 
autoantibodies. 
The incidence of CLL in farmers is higher than others occupations (52 %.of all) with a P valu <.004 which 
may be due to the use of chemical substances in the agriculture processes.  In spite of increased positive 
results in males (68 %) more than females (32%) the statistical analysis showed that there is no significant 
difference according to gender (P= 0.9).   
Thirty one cases of the total of 50 are above 50year and have autoimmune antibodies with a significant 
difference with other age groups.  According to Francesca (10) study which is carried out on the entire series 
of 1203 patients, age (P = .01), and gender (P < .01) emerged as independent factors significantly related 
to the occurrence of DAT-positive anemia (AIHA) at the time of CLL diagnosis., older age, and male gender 
were significantly linked with an increased rate of IAHA at CLL diagnosis. 
 At multivariate analysis, gender and age emerged as independent factors significantly correlated with the 
occurrence of AIHA. Men and aged patients showed a significantly higher rate of AIHA. Although there is 
no explanation for the higher rate of AIHA among men, the higher number of AIHA among elderly patients 
is not surprising (11). It is possible that, an impaired function of the aged thymus may lead to an imbalance 
among autoregulatory CD4+ and autoreactive T-lymphocyte subsets that may predispose to autoimmunity. 
(12)   
According to the duration of disease 10 cases (20%) of all patients have a duration more than 17 months, 7 
of them were positive to direct Comb’s test , the analysis confirmed that there is significance relation(P< 
0.019) between the duration of disease and the appearance AIHA . 
In conclusion, this study indicates that an autoimmune antibody is a common event in CLL with a 
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significantly higher incidence in older male patients. 
 
Conclusions and recommendations: 
An autoimmune antibody is a common event in CLL with a significantly higher incidence in outdoor 
workers (farmers) and in patients who have disease for a long duration. Autoantibody screening test must 
be used as routine test for CLL patients, which can help in improving their management and controlling the 
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